The combined serum levels of<i>miR-375</i>and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer
Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Helge Täubert(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Thomas Greither(Martin Luther University Halle-Wittenberg), Arndt Hartmann(Universitätsklinikum Erlangen), Paolo Fornara(Martin Luther University Halle-Wittenberg), Elke Nolte(Universitätsklinikum Erlangen), Katrin Weigelt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gerit Theil(University Hospital in Halle), Omar Al‐Janabi(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hans-Juergen Holzhausen(Martin Luther University Halle-Wittenberg), Verena Huppert(Friedrich-Alexander-Universität Erlangen-Nürnberg), Kersten Fischer(Martin Luther University Halle-Wittenberg), Marios Marcou(Martin Luther University Halle-Wittenberg)
Cited by 53
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Toward the blood-borne miRNome of human diseases
|Nature Methods|2011|364
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258